DNA fragmentation: a skeptic sees a bright future
Foreword

DNA fragmentation: a skeptic sees a bright future

Male infertility is, perhaps, one of the most complex and poorly understood disease processes in medicine. While some causes of male infertility are clear, the overwhelming majority, remain unknown. Our current treatment approach is to optimize male lifestyle/exposures, endocrine profile, varicocele status (where appropriate) and retrieve sperm or relieve obstruction.

One analogy that is frequently used is that it is as if we are treating every type of cancer with the same type of chemotherapy, radiation and surgical procedure and hoping for the best outcome. While some causes of male infertility are obvious, such as karyotype abnormalities or Y chromosome microdeletions, most are “n=1 problems”. The issue is that whatever genetic derangement arises in 1 of 3,500 genes critical for spermatogenesis, may be unique to an individual man. Further, it often arises de novo, and, by its very nature, is not propagated.

Tests such as DNA fragmentation, which I was previously very skeptical about, are demonstrating more and more relevance to ascertaining the etiology of male infertility. Further, with more and more literature demonstrating the benefit of using testicular vs. ejaculated sperm in the setting of in vitro fertilization (IVF) failure where men have high levels of DNA fragmentation in their ejaculated sperm, there is now a clear actionable item that arises solely from appropriate use of this test. Previously, as the authors pointed out, many andrologists would repair a high-grade varicocele in a man with normal semen parameters and IVF failure, regardless of DNA fragmentation. However, the additional data demonstrating efficacy of using testicular sperm in the setting of high levels of DNA fragmentation in ejaculated sperm make this paper a timely and important publication.

In addition to drawing attention to the fact that this test is now routinely deployed by andrologists, it also points out that some of the major limitations of the test stem from the lack of clear consensus and reproducibility from lab to lab on what constitutes an abnormal value. Nonetheless, it appears that DNA fragmentation testing now has a significant place in the armamentarium of diagnostic tests for reproductive urologists and andrologists.


Acknowledgements

None.

James M. Hotaling

James M. Hotaling, MD, MS, FECSM

Assistant Prof. of Surgery (Urology);
Adjunct Assistant Prof. of Obstetrics and Gynecology; Co-director of Fertility Integrated Practice Unit, University of Utah School of Medicine, Salt Lake City, UT, USA.
(Email: jim.hotaling@hsc.utah.edu)

doi: 10.21037/tau.2017.09.03

Conflicts of Interest: The author has no conflicts of interest to declare.

Cite this article as: Hotaling JM. DNA fragmentation: a skeptic sees a bright future. Transl Androl Urol 2017;6(Suppl 4):S334. doi: 10.21037/tau.2017.09.03